Lv13
60 积分 2024-10-12 加入
Early Clinical Experience of Finerenone in People with Chronic Kidney Disease and Type 2 Diabetes in Japan—A Multi-Cohort Study from the FOUNTAIN
7天前
已完结
Early Clinical Experience of Finerenone in People with Chronic Kidney Disease and Type 2 Diabetes in Japan—A Multi-Cohort Study from the FOUNTAIN (FinerenOne mUltidatabase NeTwork for Evidence generAtIoN) Platform
7天前
已完结
Efficacy and safety of finerenone in chronic kidney disease and type 2 diabetes patients: A systematic review and meta-Analysis
7天前
已完结
CAR T-cell therapy rescues adolescent with rapidly progressive lupus nephritis from haemodialysis
10天前
已完结
Efficacy and Safety of Finerenone Across the Ejection Fraction Spectrum in Heart Failure with Mildly Reduced and Preserved Ejection Fraction: a Prespecified Analysis of The FINEARTS-HF Trial
10天前
已完结
Mineralocorticoid receptor antagonists and reno-protection: What's the evidence & where do they fit? A guide for non-specialists
10天前
已完结
Real‐world impact of adding a glucagon‐like peptide‐1 receptor agonist compared with basal insulin on metabolic targets in adults living with type 2 diabetes and chronic kidney disease already treated with a sodium‐glucose co‐transporter‐2 inhibitor: The Impact GLP‐1 CKD study
13天前
已完结
Echocardiographic parameters dynamically alter in patients with chronic kidney disease between pre- and post-dialysis
14天前
已完结
Finerenone Reduces New-Onset Atrial Fibrillation in Patients With Chronic Kidney Disease and Type 2 Diabetes
17天前
已完结
皖公网安备34019202002308
